» Articles » PMID: 25504416

An Imagable and Photothermal "Abraxane-like" Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors

Overview
Journal Adv Mater
Date 2014 Dec 16
PMID 25504416
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

A new "Abraxane-like" nanotheranostic formulation self-assembled from three clinically approved agents, human serum albumin, paclitaxel, and indocyanine green, is developed. Utilizing such a newly formulated nanodrug, combined photothermal and chemotherapy is conducted under the guidance of imaging, not only effectively eliminating subcutaneous tumors, but also significantly inhibiting the development of metastatic tumors in this proof-of-concept study.

Citing Articles

Dual-functional silver nanoparticle-enhanced ZnO nanorods for improved reactive oxygen species generation and cancer treatment.

Tao Y, Zhuang W, Fan W, Zhou L, Fan L, Qin H iScience. 2025; 28(2):111858.

PMID: 40017508 PMC: 11867527. DOI: 10.1016/j.isci.2025.111858.


Machine Learning-Driven Prediction, Preparation, and Evaluation of Functional Nanomedicines Via Drug-Drug Self-Assembly.

Zhang C, Yuan Y, Xia Q, Wang J, Xu K, Gong Z Adv Sci (Weinh). 2025; 12(9):e2415902.

PMID: 39792782 PMC: 11884566. DOI: 10.1002/advs.202415902.


Nanotheranostics in Breast Cancer Bone Metastasis: Advanced Research Progress and Future Perspectives.

Miao L, Zhu Y, Chang H, Zhang X Pharmaceutics. 2025; 16(12.

PMID: 39771471 PMC: 11676679. DOI: 10.3390/pharmaceutics16121491.


A Nanotheranostic Agent for Synergistic Antitumor Chemo/Phototherapy Prepared by Paclitaxel-Induced Self-Assembly of PEGylated Human Serum Albumin with Prolonged Circulation.

Liu C, Xu W, Song X, Tian W, Liu F, Wang F ACS Omega. 2025; 9(52):51062-51072.

PMID: 39758671 PMC: 11696392. DOI: 10.1021/acsomega.4c05986.


Effect and underlying mechanism of a photochemotherapy dual-function nanodrug delivery system for head and neck squamous cell carcinoma.

Lin Q, Liu H, Wu L, Yu D, Hua C, Zou Y J Transl Med. 2024; 22(1):1043.

PMID: 39563418 PMC: 11577851. DOI: 10.1186/s12967-024-05855-8.